Pharmaceutical composition for oral administration of cannabinoids
AssigneeEmpowerpharm Inc.
InventorsChirag Rameshkumar SHAH, Hemang Rameshchandra JOSHI, Joseph SCHWARZ, Michael WEISSPAPIR
Life of this patent
Estimating the term…
Loading patent…
AssigneeEmpowerpharm Inc.
InventorsChirag Rameshkumar SHAH, Hemang Rameshchandra JOSHI, Joseph SCHWARZ, Michael WEISSPAPIR
Estimating the term…
A pharmaceutical composition in the form of a compressed tablet for oral administration. The composition has an intragranular portion including a first porous solid carrier with a physiologically acceptable salt that is soluble in gastric fluid/an acidic aqueous media, and a self-nanoemulsifying drug delivery system (SNEDDS) adsorbed on the carrier. The SNEDDS includes: at least one cannabinoid; one or more solubilizing agents selected from physiologically acceptable organic compounds including: alcohols C8-C18, cyclic alcohols, aromatic alcohols, glycerides, polyethylene glycols, polyethylene glycol esters, aromatic esters, phenols, tocopherols, phospholipids, polyoxylglycerides, or polyoxyethylene stearates; one or more emulsifying agents selected from physiologically acceptable nonionic surfactants; and one or more carrier oils. The composition has an extragranular portion including: an optional second porous solid carrier including a physiologically acceptable salt that is soluble in gastric fluid/an acidic aqueous media; one or more disintegrants; one or more diluents; and one or more lubricants.
1-30. (canceled)
A pharmaceutical composition in the form of a compressed tablet for oral administration having an intragranular portion and an extragranular portion, wherein:
Dependencies are inferred from the claim text.